Bank of New York Mellon’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,162
| Closed | -$8.72K | – | 4096 |
|
|
2024
Q2 | $8.72K | Buy |
2,162
+250
| +13% | +$1.01K | ﹤0.01% | 4096 |
|
|
2024
Q1 | $11.2K | Sell |
1,912
-334
| -15% | -$1.97K | ﹤0.01% | 4116 |
|
|
2023
Q4 | $8.33K | Buy |
2,246
+334
| +17% | +$1.24K | ﹤0.01% | 4268 |
|
|
2023
Q3 | $10.6K | Hold |
1,912
| – | – | ﹤0.01% | 4283 |
|
|
2023
Q2 | $20.9K | Hold |
1,912
| – | – | ﹤0.01% | 4274 |
|
|
2023
Q1 | $23.9K | Sell |
1,912
-250
| -12% | -$3.12K | ﹤0.01% | 4284 |
|
|
2022
Q4 | $21.5K | Hold |
2,162
| – | – | ﹤0.01% | 4344 |
|
|
2022
Q3 | $26K | Buy |
2,162
+53
| +3% | +$637 | ﹤0.01% | 4412 |
|
|
2022
Q2 | $31K | Buy |
2,109
+231
| +12% | +$3.4K | ﹤0.01% | 4442 |
|
|
2022
Q1 | $34K | Buy |
+1,878
| New | +$34K | ﹤0.01% | 4570 |
|
|
2017
Q3 | – | Sell |
-176
| Closed | -$9K | – | 4276 |
|
|
2017
Q2 | $9K | Buy |
176
+77
| +78% | +$3.94K | ﹤0.01% | 4269 |
|
|
2017
Q1 | $10K | Buy |
+99
| New | +$10K | ﹤0.01% | 4251 |
|
|
2016
Q4 | – | Sell |
-99
| Closed | -$13K | – | 4265 |
|
|
2016
Q3 | $13K | Sell |
99
-2
| -2% | -$263 | ﹤0.01% | 4237 |
|
|
2016
Q2 | $26K | Buy |
101
+3
| +3% | +$772 | ﹤0.01% | 4249 |
|
|
2016
Q1 | $32K | Sell |
98
-162
| -62% | -$52.9K | ﹤0.01% | 4132 |
|
|
2015
Q4 | $87K | Buy |
260
+162
| +165% | +$54.2K | ﹤0.01% | 4059 |
|
|
2015
Q3 | $43K | Buy |
+98
| New | +$43K | ﹤0.01% | 4204 |
|